To further confirm whether methylation directly contributed to RSPO4 silencing, cancer cell lines with RSPO4 methylation/silencing were treated with DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine (Aza) in conjunction with HDAC inhibitor trichostatin A (TSA). Here, RSPO4 is linked to cancer.